• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ZFHX3 敲低通过增强氧化应激和钙超载使心房肌细胞的线粒体适应心动过速失调。

ZFHX3 knockdown dysregulates mitochondrial adaptations to tachypacing in atrial myocytes through enhanced oxidative stress and calcium overload.

机构信息

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

出版信息

Acta Physiol (Oxf). 2021 Apr;231(4):e13604. doi: 10.1111/apha.13604. Epub 2020 Dec 29.

DOI:10.1111/apha.13604
PMID:33332716
Abstract

AIM

To investigate the role of zinc finger homeobox 3 gene (ZFHX3) in tachypacing-induced mitochondrial dysfunction and explore its molecular mechanisms and potential as a therapeutic target in atrial fibrillation (AF).

METHODS

Through a bioluminescent assay, a patch clamp, confocal fluorescence and fluorescence microscopy, microplate enzyme activity assays and Western blotting, we studied ATP and ADP production, mitochondrial electron transfer chain complex activities, ATP-sensitive potassium channels (I ), mitochondrial oxidative stress, Ca content, and protein expression in control and ZFHX3 knockdown (KD) HL-1 cells subjected to 1 and 5-Hz pacing for 24 hours.

RESULTS

Compared with 1-Hz pacing, 5-Hz pacing increased ATP and ADP production, I , phosphorylated adenosine monophosphate-activated protein kinase and inositol 1,4,5-triphosphate (IP ) receptor (IP R) protein expression. Tachypacing induced mitochondrial oxidative stress and Ca overload in both cell types. Furthermore, under 1- and 5-Hz pacing, ZFHX3 KD cells showed higher I , ATP and ADP production, mitochondrial oxidative stress and Ca content than control cells. Under 5-Hz pacing, 2-aminoethoxydiphenyl borate (2-APB; 3 μmol/L, an IP R inhibitor) and MitoTEMPO (10 µmol/L, a mitochondria-targeted antioxidant) reduced ADP and increased ATP production in both cell types; however, only 2-APB significantly reduced mitochondrial Ca overload in control cells. Under 5-Hz pacing, mitochondrial oxidative stress was significantly reduced by both MitoTEMPO and 2-APB and only by 2-APB in control and ZFHX3 KD cells respectively.

CONCLUSION

ZFHX3 KD cells modulate mitochondrial adaptations to tachypacing in HL-1 cardiomyocytes through Ca overload, oxidative stress and metabolic disorder. Targeting IP R signalling or oxidative stress could reduce AF.

摘要

目的

探讨锌指同源盒 3 基因(ZFHX3)在快速起搏诱导的线粒体功能障碍中的作用,并探讨其在心房颤动(AF)中的分子机制和作为治疗靶点的潜力。

方法

通过生物发光测定法、膜片钳、共聚焦荧光和荧光显微镜、微量板酶活性测定法和 Western blot 法,我们研究了对照和 ZFHX3 敲低(KD)HL-1 细胞在 1 和 5-Hz 起搏 24 小时后 ATP 和 ADP 的产生、线粒体电子传递链复合物活性、ATP 敏感性钾通道(I )、线粒体氧化应激、Ca 含量和蛋白表达。

结果

与 1-Hz 起搏相比,5-Hz 起搏增加了 ATP 和 ADP 的产生、I 、磷酸化的腺苷一磷酸激活蛋白激酶和肌醇 1,4,5-三磷酸(IP )受体(IP R)蛋白的表达。快速起搏导致两种细胞类型中线粒体氧化应激和 Ca 超载。此外,在 1-和 5-Hz 起搏下,ZFHX3 KD 细胞的 I 、ATP 和 ADP 产生、线粒体氧化应激和 Ca 含量均高于对照细胞。在 5-Hz 起搏下,2-氨基乙氧基二苯硼酸盐(2-APB;3 μmol/L,IP R 抑制剂)和 MitoTEMPO(10 μmol/L,线粒体靶向抗氧化剂)降低了两种细胞类型的 ADP 并增加了 ATP 的产生;然而,只有 2-APB 显著降低了对照细胞中线粒体 Ca 的超载。在 5-Hz 起搏下,MitoTEMPO 和 2-APB 均显著降低了线粒体氧化应激,而仅 2-APB 降低了对照和 ZFHX3 KD 细胞中的线粒体氧化应激。

结论

ZFHX3 KD 细胞通过 Ca 超载、氧化应激和代谢紊乱调节 HL-1 心肌细胞对快速起搏的线粒体适应。靶向 IP R 信号或氧化应激可能减少 AF。

相似文献

1
ZFHX3 knockdown dysregulates mitochondrial adaptations to tachypacing in atrial myocytes through enhanced oxidative stress and calcium overload.ZFHX3 敲低通过增强氧化应激和钙超载使心房肌细胞的线粒体适应心动过速失调。
Acta Physiol (Oxf). 2021 Apr;231(4):e13604. doi: 10.1111/apha.13604. Epub 2020 Dec 29.
2
MicroRNA-133 suppresses ZFHX3-dependent atrial remodelling and arrhythmia.MicroRNA-133 抑制 ZFHX3 依赖性心房重构和心律失常。
Acta Physiol (Oxf). 2019 Nov;227(3):e13322. doi: 10.1111/apha.13322. Epub 2019 Jun 18.
3
Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation.三磷酸肌醇受体与心房颤动中的核钙
Circ Res. 2021 Mar 5;128(5):619-635. doi: 10.1161/CIRCRESAHA.120.317768. Epub 2020 Dec 30.
4
ZFHX3 knockdown increases arrhythmogenesis and dysregulates calcium homeostasis in HL-1 atrial myocytes.ZFHX3基因敲低增加HL-1心房肌细胞的心律失常发生并使钙稳态失调。
Int J Cardiol. 2016 May 1;210:85-92. doi: 10.1016/j.ijcard.2016.02.091. Epub 2016 Feb 17.
5
Tachypacing-induced CREB/CD44 signaling contributes to the suppression of L-type calcium channel expression and the development of atrial remodeling.快频率起搏诱导的 CREB/CD44 信号通路促进 L 型钙通道表达的抑制和心房重构的发生。
Heart Rhythm. 2021 Oct;18(10):1760-1771. doi: 10.1016/j.hrthm.2021.05.021. Epub 2021 May 20.
6
TPEN prevents rapid pacing-induced calcium overload and nitration stress in HL-1 myocytes.
Cardiovasc Ther. 2015 Aug;33(4):200-8. doi: 10.1111/1755-5922.12134.
7
Effect of TFAM on ATP content in tachypacing primary cultured cardiomyocytes and atrial fibrillation patients.TFAM 对心动过速起搏原代培养心肌细胞及心房颤动患者 ATP 含量的影响。
Mol Med Rep. 2020 Dec;22(6):5105-5112. doi: 10.3892/mmr.2020.11593. Epub 2020 Oct 14.
8
Down-regulation of ATBF1 activates STAT3 signaling via PIAS3 in pacing-induced HL-1 atrial myocytes.ATBF1 的下调通过 PIAS3 激活起搏诱导的 HL-1 心房肌细胞中的 STAT3 信号通路。
Biochem Biophys Res Commun. 2014 Jul 4;449(3):278-83. doi: 10.1016/j.bbrc.2014.05.041. Epub 2014 May 21.
9
Loss of the Atrial Fibrillation-Related Gene, , Results in Atrial Dilation and Arrhythmias.缺失与心房颤动相关的基因 , 导致心房扩张和心律失常。
Circ Res. 2023 Aug 4;133(4):313-329. doi: 10.1161/CIRCRESAHA.123.323029. Epub 2023 Jul 14.
10
Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.转化生长因子-β和氧化应激介导心动过速诱导的培养心房来源心肌细胞的重构。
Cardiovasc Res. 2011 Jul 1;91(1):62-70. doi: 10.1093/cvr/cvr041. Epub 2011 Feb 2.

引用本文的文献

1
ZFHX3 Knockdown Enhances Metabolic Distress in Atrial Myocytes Through Mitochondrial and Calcium Dysregulation: Mitigation by Trimetazidine.锌指同源盒蛋白3(ZFHX3)敲低通过线粒体和钙调节异常增强心房肌细胞的代谢应激:曲美他嗪的缓解作用
Int J Mol Sci. 2025 Sep 3;26(17):8576. doi: 10.3390/ijms26178576.
2
Electrophysiological Mechanisms and Therapeutic Potential of Calcium Channels in Atrial Fibrillation.心房颤动中钙通道的电生理机制及治疗潜力
Rev Cardiovasc Med. 2025 Jun 25;26(6):33507. doi: 10.31083/RCM33507. eCollection 2025 Jun.
3
New-Onset Atrial Fibrillation in Patients with Pacemakers and the Implications of Hepatic Impairment.
起搏器植入患者新发心房颤动及肝功能损害的影响
Life (Basel). 2025 Mar 13;15(3):450. doi: 10.3390/life15030450.
4
Mitochondrial dysfunction is a key link involved in the pathogenesis of sick sinus syndrome: a review.线粒体功能障碍是病态窦房结综合征发病机制中的关键环节:综述
Front Cardiovasc Med. 2024 Oct 29;11:1488207. doi: 10.3389/fcvm.2024.1488207. eCollection 2024.
5
Factors predicting the recurrence of atrial fibrillation after catheter ablation: A review.导管消融术后心房颤动复发的预测因素:综述
Heliyon. 2024 Jul 6;10(13):e34205. doi: 10.1016/j.heliyon.2024.e34205. eCollection 2024 Jul 15.
6
Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation.非酒精性脂肪性肝病中增加心房颤动易感性的关键基因鉴定及潜在机制:线粒体功能障碍和全身炎症
Front Pharmacol. 2024 Mar 14;15:1360974. doi: 10.3389/fphar.2024.1360974. eCollection 2024.
7
Loss of the Atrial Fibrillation-Related Gene, , Results in Atrial Dilation and Arrhythmias.缺失与心房颤动相关的基因 , 导致心房扩张和心律失常。
Circ Res. 2023 Aug 4;133(4):313-329. doi: 10.1161/CIRCRESAHA.123.323029. Epub 2023 Jul 14.
8
Editorial: Transcription factors and arrhythmogenesis.社论:转录因子与心律失常的发生机制
Front Physiol. 2023 Feb 28;14:1169747. doi: 10.3389/fphys.2023.1169747. eCollection 2023.
9
Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention.糖尿病中心脏代谢紊乱触发心律失常发生的机制:能量底物改变可能成为一种潜在的治疗干预手段。
Cells. 2022 Sep 18;11(18):2915. doi: 10.3390/cells11182915.
10
Functional Regulation of K Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases.钾通道的功能调节及心血管疾病临床治疗策略的突变体见解
Front Pharmacol. 2022 Jun 28;13:868401. doi: 10.3389/fphar.2022.868401. eCollection 2022.